Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,979,789 papers from all fields of science
Search
Sign In
Create Free Account
KH 1060
Known as:
1,3-Cyclohexanediol, 5-((1-(1-((4-ethyl-4-hydroxyhexyl)oxy)ethyl)octahydro-7a-methyl-4H-inden-4-ylidene)ethylidene)-4-methylene-, (1S-(1alpha(S*),3abeta,4E(1S*,3R*,5Z),7aalpha))-
, KH-1060
, KH1060
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (3)
Antineoplastic Agents
Calcitriol
Immunosuppressive Agents
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
1,25-dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax.
N. Wagner
,
K. Wagner
,
G. Schley
,
L. Badiali
,
H. Theres
,
H. Scholz
Experimental Eye Research
2003
Corpus ID: 23124080
2003
2003
Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein.
S. Ryhänen
,
T. Jääskeläinen
,
A. Mahonen
,
P. Mäenpää
Biochemical Pharmacology
2003
Corpus ID: 2480041
1999
1999
Vitamin D Analogs, 20-Epi-22-Oxa-24a,26a,27a,-Trihomo-1α,25(OH)2-Vitamin D3, 1,24(OH)2-22-Ene-24-Cyclopropyl-Vitamin D3 and 1α,25(OH)2-Lumisterol3 Prime NB4 Leukemia Cells for Monocytic…
D. Berry
,
K. A. Meckling-Gill
Endocrinology
1999
Corpus ID: 43295379
Side-chain modified vitamin D analogs including 20-Epi-22-oxa-24a,26a,27a-trihomo-1α,25-dihydroxyvitamin D3 (KH1060), and 1,24…
Expand
1997
1997
The vitamin D analog, KH1060, is rapidly degraded both in vivo and in vitro via several pathways: principal metabolites generated retain significant biological activity.
F. J. Dilworth
,
G. Williams
,
+5 authors
G. Jones
Endocrinology
1997
Corpus ID: 6343858
Vitamin D analogs are valuable drugs with established and potential uses in hyperproliferative disorders. Lexacalcitol (KH1060…
Expand
1997
1997
Interaction of vitamin D derivatives and granulocyte–macrophage colony-stimulating factor in leukaemic cell differentiation
S. James
,
MA Williams
,
S. Kelsey
,
A. Newland
,
K. Colston
Leukemia
1997
Corpus ID: 42355708
The ability of the physiologically active form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and two novel vitamin D…
Expand
1996
1996
Calcitriol and lexicalcitol (KH1060) inhibit the growth of human breast adenocarcinoma cells by enhancing transforming growth factor-beta production.
T. Mercier
,
Catherine Chaumontet
,
I. Gaillard‐Sanchez
,
Pauk Martel
,
C. Heberden
Biochemical Pharmacology
1996
Corpus ID: 38152362
1995
1995
The effects of KH 1060, a potent 20‐epi analogue of the vitamin D3 hormone, on hairless mouse skin in vivo
R. Gniadecki
,
M. Gniadecka
,
J. Serup
British Journal of Dermatology
1995
Corpus ID: 25462497
Summary Dermal effects of KH 1060, a novel, highly potent 20‐epi analogue of 1α,25‐dihyroxyvitamin D3, were investigated in a…
Expand
Highly Cited
1994
Highly Cited
1994
All-trans retinoic acid and 1 alpha,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes.
G. Brown
,
C. Bunce
,
D. Rowlands
,
G. Williams
Leukemia
1994
Corpus ID: 29382091
A basis for differentiation therapy of leukemias is provided by knowledge of agents which induce specific lineage maturation. All…
Expand
1993
1993
1,25‐dihydroxyvitamin D3 and the vitamin D analogue KH1060 induce hyperproliferation in normal mouse epidermis
C. Lützow-Holm
,
P. Angelis
,
H. Grøsvik
,
O. Clausen
Experimental Dermatology
1993
Corpus ID: 44377277
Abstract 1,25‐dihydroxyvitamin D3 (calcitriol) affects differentiation and proliferation of epidermal keratinocytes in vitro and…
Expand
1989
1989
VITAMIN D AND BREAST CANCER
J. Eisman
,
T. Martin
,
R. Coombes
,
K. Colston
The Lancet
1989
Corpus ID: 20240326
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE